Bioclavid: Uses, Dosage & Side Effects
A combination antibiotic containing amoxicillin and clavulanic acid, used to treat bacterial infections resistant to amoxicillin alone
Bioclavid is a prescription antibiotic that combines two active substances: amoxicillin and clavulanic acid. Amoxicillin is a penicillin-type antibiotic that kills bacteria causing infections, while clavulanic acid is a beta-lactamase inhibitor that prevents certain bacteria from inactivating amoxicillin. This combination makes Bioclavid effective against a broader range of bacteria, including many strains that have become resistant to amoxicillin alone. It is prescribed for adults and children to treat infections of the ears, sinuses, respiratory tract, urinary tract, skin, soft tissues, bones, and joints. Amoxicillin/clavulanic acid is listed on the WHO Model List of Essential Medicines and is one of the most widely used antibiotic combinations worldwide.
Quick Facts: Bioclavid
Key Takeaways
- Bioclavid contains amoxicillin and clavulanic acid, making it effective against bacteria that are resistant to standard amoxicillin by producing beta-lactamase enzymes.
- It is prescribed for infections of the ears, sinuses, respiratory tract, urinary tract, skin, soft tissues, bones, and joints in both adults and children.
- The standard adult dose is one 500 mg/125 mg tablet three times daily, taken at the beginning of a meal with at least 4 hours between doses.
- The most common side effect is diarrhea; taking the tablet with food helps reduce nausea and gastrointestinal discomfort.
- Do not take Bioclavid if you are allergic to penicillin or if you have previously experienced liver problems or jaundice associated with amoxicillin/clavulanic acid.
What Is Bioclavid and What Is It Used For?
Quick Answer: Bioclavid is a combination antibiotic containing amoxicillin (a penicillin antibiotic) and clavulanic acid (a beta-lactamase inhibitor). Together, they treat bacterial infections that amoxicillin alone cannot effectively manage because the bacteria produce enzymes that would otherwise destroy the antibiotic.
Bioclavid belongs to a class of antibiotics known as penicillins combined with beta-lactamase inhibitors. The amoxicillin component works by interfering with bacterial cell wall synthesis. Specifically, it binds to penicillin-binding proteins (PBPs) inside bacterial cells, disrupting the cross-linking of peptidoglycan chains that give the cell wall its structural integrity. Without a functional cell wall, bacteria cannot maintain their shape or osmotic balance, ultimately leading to cell lysis and death.
However, many bacteria have evolved a defence mechanism: they produce enzymes called beta-lactamases that break down the beta-lactam ring of penicillin antibiotics like amoxicillin, rendering them inactive. This is where clavulanic acid plays its critical role. Although clavulanic acid has minimal antibacterial activity on its own, it acts as a “suicide inhibitor” by irreversibly binding to the active site of bacterial beta-lactamase enzymes. By neutralizing these enzymes, clavulanic acid restores the full bactericidal activity of amoxicillin against resistant organisms.
This combination extends the antibacterial spectrum of amoxicillin to include important beta-lactamase-producing pathogens such as Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli, and Klebsiella pneumoniae. The clinical relevance of this extended spectrum is significant, as beta-lactamase production is one of the most common mechanisms of antibiotic resistance encountered in clinical practice.
Approved Indications
Bioclavid is used in adults and children for the treatment of the following bacterial infections:
- Middle ear infections (acute otitis media) – Particularly when caused by beta-lactamase-producing H. influenzae or M. catarrhalis, which are common in recurrent ear infections.
- Sinus infections (acute sinusitis) – When the infection does not respond to amoxicillin alone or when beta-lactamase-producing organisms are suspected.
- Respiratory tract infections – Including acute exacerbations of chronic bronchitis and community-acquired pneumonia, especially when mixed bacterial flora are involved.
- Urinary tract infections – Both lower urinary tract infections (cystitis) and upper urinary tract infections (pyelonephritis) caused by susceptible organisms.
- Skin and soft tissue infections – Including cellulitis, wound infections, and animal bite wounds, where mixed aerobic and anaerobic bacteria are often present.
- Dental infections – Such as dental abscesses and pericoronitis where infection has spread beyond the tooth into surrounding tissues.
- Bone and joint infections – Osteomyelitis and septic arthritis caused by susceptible bacteria, often as part of a longer treatment course.
Your doctor determines whether Bioclavid is the appropriate treatment based on the type, location, and severity of the infection, as well as local antibiotic resistance patterns. In many countries, clinical guidelines recommend reserving amoxicillin/clavulanic acid for situations where plain amoxicillin is insufficient, as part of responsible antibiotic stewardship.
Bioclavid only works against bacterial infections. It has no effect on viral infections such as the common cold, influenza, or most cases of sore throat. Using antibiotics when they are not needed increases the risk of antibiotic resistance, a growing global health threat recognized by the WHO as one of the top ten threats to public health.
What Should You Know Before Taking Bioclavid?
Quick Answer: Do not take Bioclavid if you are allergic to penicillin, clavulanic acid, or any other beta-lactam antibiotic. You should also avoid it if you have previously experienced liver problems or jaundice when taking an antibiotic. Always inform your doctor about all medical conditions and medications before starting treatment.
Contraindications
Bioclavid must not be taken in the following circumstances:
- Known allergy to amoxicillin, clavulanic acid, penicillin, or any inactive ingredient in the tablet. Penicillin allergy affects approximately 1–10% of the general population, though confirmed allergy upon testing is found in less than 1% of those who report it.
- Previous severe allergic reaction (hypersensitivity) to any antibiotic. This includes reactions involving skin rash, facial or throat swelling (angioedema), or anaphylaxis. Cross-reactivity between penicillins and cephalosporins can occur in approximately 1–2% of penicillin-allergic individuals.
- Previous liver problems or jaundice (yellowing of the skin or eyes) associated with taking amoxicillin/clavulanic acid or any other antibiotic. Hepatic events related to co-amoxiclav are generally self-limiting but can be severe in rare cases.
Warnings and Precautions
Before starting Bioclavid, tell your doctor if you:
- Have glandular fever (infectious mononucleosis) – Patients with this condition who take amoxicillin-containing products frequently develop a widespread non-allergic skin rash. This rash is not a true allergy but can be mistaken for one.
- Are being treated for liver or kidney problems – Your doctor may need to adjust the dose or choose an alternative medicine. In patients with impaired renal function, the dose should be adjusted according to creatinine clearance. Regular liver function monitoring may be recommended during prolonged treatment.
- Are not urinating regularly – Adequate fluid intake and regular urination help prevent the rare complication of crystalluria (crystals forming in the urine).
If you are having blood tests (such as red blood cell counts or liver function tests) or urine tests (for glucose), inform your doctor or nurse that you are taking Bioclavid. This medicine can affect the results of these tests. In particular, non-enzymatic urine glucose tests may give false-positive results.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, or are planning to have a baby, consult your doctor before taking Bioclavid. Animal studies have not shown direct harmful effects on the developing foetus, and amoxicillin/clavulanic acid is considered one of the safer antibiotic options during pregnancy when a bacterial infection requires treatment. However, one study in women with preterm premature rupture of membranes (PPROM) suggested a possible increase in the risk of necrotizing enterocolitis in neonates, so the decision to use it should always be made by your doctor after careful risk-benefit assessment.
Both amoxicillin and clavulanic acid are excreted in small amounts in breast milk. While significant adverse effects in breastfed infants are uncommon, the infant should be monitored for possible gastrointestinal disturbance (diarrhea or thrush). If the breastfed infant develops any adverse effects, breastfeeding should be discontinued or the medicine changed, as advised by your doctor.
Driving and Operating Machinery
Bioclavid may cause side effects such as dizziness or seizures (particularly at high doses or in patients with renal impairment) that could impair your ability to drive or operate machinery safely. Do not drive or use machines if you experience any symptoms that affect your alertness or coordination. Assess your own fitness before engaging in activities that require concentration.
Sodium Content
Bioclavid film-coated tablets contain less than 1 mmol (23 mg) sodium per tablet, meaning they are essentially sodium-free. This is relevant for patients on sodium-restricted diets, such as those with heart failure or hypertension.
How Does Bioclavid Interact with Other Drugs?
Quick Answer: Bioclavid can interact with several medications, including allopurinol, probenecid, warfarin, methotrexate, and mycophenolate mofetil. Always inform your doctor about all medications you are currently taking, including over-the-counter medicines and supplements.
Drug interactions can alter how a medication works or increase the risk of side effects. Before starting Bioclavid, provide your doctor or pharmacist with a complete list of all medicines you use. The most clinically significant interactions are summarized below.
| Interacting Drug | Effect | Clinical Significance | Action Required |
|---|---|---|---|
| Allopurinol | Increased risk of allergic skin reactions (rash) | Moderate | Monitor for skin rash; consider alternative if rash occurs |
| Probenecid | Reduces renal excretion of amoxicillin, increasing blood levels | Significant | Concurrent use not recommended; dose adjustment may be needed |
| Warfarin | Potential increase in anticoagulant effect (increased INR) | Significant | More frequent INR monitoring; dose adjustment of warfarin as needed |
| Methotrexate | Reduced renal clearance of methotrexate, increased toxicity risk | Serious | Close monitoring of methotrexate levels; watch for signs of toxicity |
| Mycophenolate mofetil | May reduce plasma levels of the active metabolite mycophenolic acid | Moderate | Monitor transplant rejection markers; adjust immunosuppression if needed |
Major Interactions
Methotrexate: Penicillins, including amoxicillin, can decrease the renal tubular secretion of methotrexate, leading to elevated methotrexate plasma concentrations and an increased risk of serious toxicity (including bone marrow suppression, mucositis, and hepatotoxicity). If concurrent use is unavoidable, methotrexate levels should be closely monitored and supportive care should be available. The British National Formulary (BNF) classifies this as a clinically significant interaction that requires active monitoring.
Warfarin and other anticoagulants: Amoxicillin/clavulanic acid has been associated with prolongation of prothrombin time and increased International Normalized Ratio (INR) in patients receiving warfarin-type oral anticoagulants. The mechanism is not fully established but may involve disruption of gut flora that produce vitamin K, thereby potentiating the anticoagulant effect. More frequent INR monitoring is strongly recommended during and shortly after concurrent therapy, and the warfarin dose may need temporary adjustment.
Minor Interactions
Allopurinol: The concurrent use of allopurinol (used to treat gout) and amoxicillin increases the likelihood of developing a maculopapular skin rash. While this rash is generally not dangerous, it can be mistaken for a true drug allergy, potentially leading to unnecessary avoidance of penicillin antibiotics in the future. Patients should be counselled about this possibility.
Probenecid: Probenecid inhibits the renal tubular secretion of amoxicillin, which increases and prolongs amoxicillin blood levels. While this interaction has historically been used therapeutically (to boost amoxicillin levels), it does not affect clavulanic acid excretion and is generally not recommended with Bioclavid without medical supervision.
Mycophenolate mofetil: In transplant recipients taking mycophenolate mofetil, amoxicillin/clavulanic acid may reduce the plasma concentrations of the active metabolite, mycophenolic acid, by approximately 50% due to disruption of enterohepatic recirculation. This could theoretically increase the risk of organ rejection. Close monitoring and possible dose adjustment of the immunosuppressant may be required.
What Is the Correct Dosage of Bioclavid?
Quick Answer: The standard adult dose of Bioclavid is one 500 mg/125 mg tablet three times daily. Swallow the tablet whole with water at the start of a meal. Space doses at least 4 hours apart and do not exceed 2 weeks of treatment without medical reassessment.
Always take Bioclavid exactly as prescribed by your doctor or pharmacist. The dose depends on the type of infection, its severity, and the patient’s age, weight, and kidney function. Do not alter your dose or stop treatment early without consulting your healthcare provider.
Adults and Children Weighing 40 kg or More
Standard Dose
1 tablet (500 mg/125 mg) three times daily
Treatment duration typically ranges from 5 to 14 days depending on the type of infection. For most common infections (sinusitis, otitis media, uncomplicated urinary tract infections), a 5–7 day course is usually sufficient. For more serious infections (pneumonia, bone infections), longer courses of up to 14 days or more may be needed, as directed by your doctor.
Children Weighing Less Than 40 kg
Pediatric Dosing
Children aged 6 years or younger should preferably be treated with an oral suspension or sachets containing amoxicillin/clavulanic acid, as these formulations allow more precise weight-based dosing.
For older children who can swallow tablets, the dose is determined by their body weight. Consult your doctor or pharmacist for the correct dose when giving Bioclavid tablets to children weighing less than 40 kg. Typical pediatric dosing is based on 25–45 mg/kg/day of the amoxicillin component divided into two or three doses, depending on the formulation and severity of infection.
Patients with Kidney or Liver Problems
Dose Adjustments
Kidney impairment: If you have reduced kidney function (estimated glomerular filtration rate below 30 mL/min), your doctor may prescribe a lower dose or an alternative formulation. This is because both amoxicillin and clavulanic acid are primarily eliminated by the kidneys, and impaired renal function leads to slower drug clearance and higher blood levels.
Liver impairment: If you have liver problems, your doctor may order more frequent blood tests to monitor liver function during treatment. Hepatic events have been reported with amoxicillin/clavulanic acid and are more common in patients over 65 years and in those receiving prolonged treatment. The risk is associated primarily with the clavulanic acid component.
| Patient Group | Dose | Frequency | Notes |
|---|---|---|---|
| Adults & children ≥40 kg | 500 mg/125 mg | 3 times daily | Take at start of meal; max 14 days without reassessment |
| Children <40 kg (>6 yrs) | Weight-based | 2–3 times daily | Oral suspension preferred for younger/lighter children |
| Children ≤6 years | Oral suspension | As prescribed | Tablets not recommended; use liquid formulation |
| Kidney impairment (GFR <30) | Reduced | Adjusted | Doctor to determine based on creatinine clearance |
| Liver impairment | Standard with monitoring | 3 times daily | Regular liver function tests recommended |
How to Take Bioclavid
Swallow the tablets whole with a full glass of water at the beginning of a meal or just before eating. Taking Bioclavid with food improves the absorption of clavulanic acid and reduces the likelihood of gastrointestinal side effects. Space your doses evenly throughout the day, maintaining at least 4 hours between each dose. Do not take two doses within 1 hour of each other.
Missed Dose
If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to compensate for a missed one. Maintaining consistent blood levels of the antibiotic is important for treatment success, so try to take your medicine at the same times each day.
Overdose
If you take too much Bioclavid, you may experience nausea, vomiting, diarrhea, or seizures. Contact your doctor, go to the nearest hospital emergency department, or call your local poison control centre immediately. Take the medicine packaging with you so healthcare professionals can identify what you have taken. In most cases, overdose is managed with supportive care, adequate hydration, and monitoring. Amoxicillin can be removed from the circulation by hemodialysis.
Completing Your Course
It is crucial to continue taking Bioclavid until the full prescribed course is completed, even if you start feeling better after a few days. Premature discontinuation of antibiotic treatment allows surviving bacteria to multiply and potentially develop resistance, which could make the infection harder to treat if it returns. If you still feel unwell after completing the course, consult your doctor for reassessment.
What Are the Side Effects of Bioclavid?
Quick Answer: The most common side effect of Bioclavid is diarrhea, which affects more than 1 in 10 adults. Other common side effects include nausea, vomiting, and thrush (candidiasis). Serious but rare side effects include severe allergic reactions, liver inflammation, and pseudomembranous colitis. Contact your doctor immediately if you develop severe symptoms.
Like all medicines, Bioclavid can cause side effects, although not everyone experiences them. Most side effects are mild and resolve on their own once treatment is completed. However, some side effects require immediate medical attention. The frequency categories used below follow the standard convention used in medical product information.
Very Common
May affect more than 1 in 10 people
- Diarrhea (in adults)
Common
May affect up to 1 in 10 people
- Thrush (candidiasis – a yeast infection of the vagina, mouth, or skin folds)
- Nausea, especially at higher doses
- Vomiting
- Diarrhea (in children)
Uncommon
May affect up to 1 in 100 people
- Skin rash, itching
- Raised, itchy rash (urticaria/hives)
- Indigestion (dyspepsia)
- Dizziness
- Headache
- Increased liver enzymes (detected on blood tests)
Rare
May affect up to 1 in 1,000 people
- Erythema multiforme (skin rash with target-like lesions)
- Low platelet count (thrombocytopenia)
- Low white blood cell count (leukopenia)
Very Rare / Frequency Unknown
May affect fewer than 1 in 10,000 people or frequency cannot be estimated
- Severe allergic reactions (anaphylaxis, angioedema)
- Vasculitis (inflammation of blood vessels)
- Pseudomembranous colitis (severe inflammation of the colon with bloody diarrhea)
- Acute pancreatitis
- Drug-induced enterocolitis (primarily in children, with vomiting 1–4 hours after ingestion)
- Aseptic meningitis (inflammation of brain membranes)
- Hepatitis (liver inflammation) and cholestatic jaundice
- Interstitial nephritis (kidney inflammation)
- Prolonged bleeding time
- Hyperactivity, seizures (especially at high doses or with renal impairment)
- Black hairy tongue
- Tooth discoloration (in children; usually reversible with brushing)
- Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)
- Acute generalized exanthematous pustulosis (AGEP)
- Drug reaction with eosinophilia and systemic symptoms (DRESS)
- Linear IgA disease (skin blistering)
- Severe reduction in white blood cells (agranulocytosis)
- Hemolytic anemia
- Crystalluria (crystals in urine, potentially causing acute kidney injury)
- Kounis syndrome (allergic chest pain/heart attack)
- Skin rash, swelling of face/mouth/throat, or difficulty breathing (allergic reaction)
- Severe watery or bloody diarrhea, with or without stomach cramps and fever (possible Clostridioides difficile colitis)
- Severe, persistent abdominal pain (possible acute pancreatitis)
- Yellowing of the skin or whites of the eyes (jaundice – possible liver involvement)
- Widespread blistering or peeling of the skin (possible SJS/TEN)
- Chest pain associated with an allergic reaction (possible Kounis syndrome)
Hepatic events (liver problems) associated with amoxicillin/clavulanic acid occur more frequently in males and elderly patients, and are more common when treatment continues for longer than 14 days. The onset of symptoms may occur during or up to several weeks after treatment has ended. Hepatic reactions are usually reversible, but in very rare cases they can be serious. Risk factors include pre-existing liver disease and concurrent use of hepatotoxic drugs.
If you experience any side effects not listed above, or if any side effect becomes severe, tell your doctor or pharmacist. Reporting suspected side effects helps healthcare authorities continue to monitor the benefit-risk balance of medicines.
How Should You Store Bioclavid?
Quick Answer: Store Bioclavid at or below 25°C (77°F) in the original packaging to protect from moisture. Keep out of the reach and sight of children. Do not use after the expiry date printed on the packaging.
Proper storage of medications is essential to maintain their efficacy and safety. Bioclavid film-coated tablets should be stored under the following conditions:
- Temperature: Store at a maximum of 25°C (77°F). Avoid exposing the tablets to excessive heat or direct sunlight.
- Moisture protection: Keep the tablets in the original packaging (blister pack or strip). Clavulanic acid is particularly sensitive to moisture, which can degrade the product if exposed.
- Child safety: Store all medicines out of the sight and reach of children.
- Expiry date: Do not use Bioclavid after the expiry date (EXP) stated on the packaging. The expiry date refers to the last day of that month.
Do not dispose of medicines via wastewater or household waste. Ask your pharmacist about proper disposal of medicines you no longer use. Proper disposal helps protect the environment, particularly aquatic ecosystems, from pharmaceutical contamination.
What Does Bioclavid Contain?
Quick Answer: Each Bioclavid tablet contains 500 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid (as potassium clavulanate), plus inactive excipients including microcrystalline cellulose, hypromellose, and titanium dioxide.
Active Ingredients
- Amoxicillin trihydrate equivalent to 500 mg amoxicillin – the main antibiotic component that kills susceptible bacteria.
- Potassium clavulanate equivalent to 125 mg clavulanic acid – the beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation.
Inactive Ingredients (Excipients)
The film-coated tablet also contains the following inactive substances:
- Magnesium stearate
- Talc
- Microcrystalline cellulose
- Triethyl citrate
- Hypromellose
- Ethylcellulose
- Titanium dioxide (E 171)
- Colloidal anhydrous silica
- Sodium starch glycolate (type A)
Appearance and Pack Sizes
Bioclavid tablets are oblong, biconvex, white to slightly yellowish, film-coated tablets embossed with “GG N6” on one side. They are available in sealed aluminium foil strips with polyethylene coating (Alu/PE) in packs of 20, 30, 100, or 100×1 tablets, or in aluminium blisters (Alu/Alu) in packs of 20, 21, 24, 30, 100, or 100×1 tablets. Not all pack sizes may be marketed in every country.
Why Is Responsible Antibiotic Use Important?
Quick Answer: Using antibiotics responsibly helps prevent bacteria from becoming resistant. Antibiotic resistance is a major global health threat identified by the WHO. Always complete your full course, never share antibiotics, and only use them when prescribed.
Antibiotics are used to treat bacterial infections, but they have no effect against viral infections. One of the most common reasons for antibiotic treatment failure is that the bacteria causing the infection have become resistant to the antibiotic being taken. This means bacteria can survive and even multiply despite the presence of the antibiotic.
Antibiotic resistance develops for a variety of reasons, but responsible use of antibiotics can help minimize the risk. The World Health Organization (WHO) has identified antimicrobial resistance as one of the top 10 global public health threats facing humanity. In 2019, drug-resistant bacterial infections were estimated to be directly responsible for approximately 1.27 million deaths worldwide and associated with nearly 5 million deaths in total, according to a landmark study published in The Lancet.
You can help combat antibiotic resistance by following these guidelines:
- Take the correct dose at the right time for the right number of days. Read the instructions on the label carefully, and ask your doctor or pharmacist if anything is unclear.
- Only take antibiotics prescribed specifically for you to treat the infection you currently have. Do not save leftover antibiotics for future illnesses.
- Never take antibiotics prescribed for someone else, even if their infection seems similar to yours. The wrong antibiotic may be ineffective or even harmful.
- Never give your antibiotics to another person.
- Return any unused antibiotics to your pharmacy for safe disposal after completing your prescribed course.
Many countries and healthcare systems have implemented antibiotic stewardship programs that guide prescribers in selecting the narrowest-spectrum, most effective antibiotic for each infection. Amoxicillin/clavulanic acid is typically reserved for infections where amoxicillin alone is insufficient, helping preserve the effectiveness of simpler antibiotics for future use.
Frequently Asked Questions About Bioclavid
Bioclavid is an antibiotic used to treat a wide range of bacterial infections. It contains amoxicillin and clavulanic acid, which together are effective against bacteria that produce beta-lactamase enzymes—a common mechanism of antibiotic resistance. It is prescribed for ear infections, sinus infections, respiratory tract infections, urinary tract infections, skin and soft tissue infections (including bite wounds), dental infections, and bone and joint infections. Your doctor will determine whether Bioclavid is appropriate based on the type of infection and local resistance patterns.
The key difference is that Bioclavid contains clavulanic acid in addition to amoxicillin. Clavulanic acid is a beta-lactamase inhibitor that prevents resistant bacteria from breaking down amoxicillin. This gives Bioclavid a broader spectrum of activity against bacteria that would otherwise be resistant to amoxicillin alone. Your doctor may prescribe Bioclavid when the infection is caused by, or suspected to be caused by, beta-lactamase-producing bacteria, or when a first-line antibiotic such as amoxicillin alone has failed.
There is no direct chemical interaction between amoxicillin/clavulanic acid and alcohol. However, alcohol can worsen gastrointestinal side effects such as nausea, vomiting, and diarrhea, which are already common with this antibiotic. Alcohol can also impair your immune system and delay recovery from infection. It is generally advisable to limit or avoid alcohol while you are unwell and being treated with antibiotics. If you have liver problems, combining alcohol and Bioclavid may increase the risk of hepatotoxicity.
Yes. Bioclavid should be taken at the beginning of a meal or just before eating. This serves two purposes: it improves the absorption of clavulanic acid from the gastrointestinal tract, and it significantly reduces the risk of gastrointestinal side effects such as nausea and stomach upset. Swallow the tablet whole with a glass of water—do not crush, chew, or break it.
Amoxicillin/clavulanic acid is generally considered one of the safer antibiotic choices during pregnancy when treatment of a bacterial infection is necessary. However, one study raised concern about a possible increase in the risk of necrotizing enterocolitis in newborns when used in mothers with preterm premature rupture of membranes. Therefore, the decision to use Bioclavid during pregnancy should always be made by your doctor after carefully weighing the benefits against the potential risks. Do not self-medicate during pregnancy.
Bioclavid begins killing bacteria soon after absorption, with amoxicillin reaching peak blood levels within 1–2 hours. However, you may not notice a significant improvement in symptoms for 24–72 hours, as the antibiotic needs time to reduce the bacterial population to a level where your immune system can take over. If you do not feel better after 48–72 hours, or if your symptoms worsen, contact your doctor, as the infection may require a different antibiotic or further investigation.
References
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List (2023). Geneva: WHO; 2023. Amoxicillin + clavulanic acid listed as an essential Access group antibiotic.
- European Medicines Agency (EMA). Amoxicillin/Clavulanic Acid – Summary of Product Characteristics (SmPC). Updated 2024. Available from EMA product database.
- U.S. Food and Drug Administration (FDA). Amoxicillin and Clavulanate Potassium Tablets – Prescribing Information. Updated 2023.
- Joint Formulary Committee. British National Formulary (BNF) – Co-amoxiclav Monograph. London: BMJ Group and Pharmaceutical Press; 2024.
- National Institute for Health and Care Excellence (NICE). Antimicrobial Prescribing Guidelines. Updated 2024. Evidence-based recommendations for antibiotic selection.
- Murray CJL, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
- Kenyon S, et al. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. The Lancet. 2001;357(9261):979–988. doi:10.1016/S0140-6736(00)04233-1
- Salvo F, et al. Amoxicillin-clavulanate hepatotoxicity: A systematic review. Journal of Hepatology. 2019;71(4):857–858.
About Our Medical Editorial Team
All medical content on iMedic is written and reviewed by a team of qualified healthcare professionals, including specialist physicians in clinical pharmacology, infectious disease, and general medicine. Our editorial process follows the GRADE evidence framework, and all drug information is cross-referenced against authoritative sources including the WHO Essential Medicines List, EMA SmPCs, FDA drug labels, and the British National Formulary.
All claims are supported by peer-reviewed research, systematic reviews, and international clinical guidelines (Evidence Level 1A where available).
iMedic receives no pharmaceutical industry funding. Our content is free from commercial influence and advertising bias.
Content is reviewed and updated regularly to reflect the latest medical evidence, guideline changes, and safety communications.
All pages meet the highest level of web accessibility standards, ensuring medical information is available to everyone regardless of ability.